Rituximab to Treat Severe Hemophilia A

NCT00331006 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Rituximab

Sponsor

Carelon Research

Collaborators

[object Object]
[object Object]